SCHEMBL23600164

SCHEMBL23600164

Cn1c(=O)nc(N2CCC(Oc3cccc(C(F)(F)F)c3)CC2)c2nc(Cl)ccc21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 5/20 0.47
▸ DGKZ Q13574 3/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TP53 P04637 1/20 0.43
▸ ACSL1 P33121 1/20 0.41
▸ SCN10A Q9Y5Y9 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ DGKA P23743 1/20 0.39
▸ EPHX2 P34913 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ LPL P06858 1/20 0.38
▸ LIPG Q9Y5X9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23600259 0.87 DGKZ (0.48) DGKZDGKA
SCHEMBL30900998 0.87 DGKZ (0.43) SCDDGKZMEN1KMT2ADGKA
SCHEMBL30900942 0.87 DGKZ (0.43) SCDDGKZMEN1KMT2AACSL1
SCHEMBL23564310 0.87 DGKZ (0.43) SCDDGKZMEN1KMT2AACSL1
SCHEMBL23526938 0.87 DGKZ (0.43) SCDDGKZMEN1KMT2AACSL1
SCHEMBL23527134 0.87 DGKZ (0.43) SCDDGKZMEN1KMT2ADGKA
SCHEMBL23527052 0.87 DGKZ (0.43) SCDDGKZMEN1KMT2ADGKA
SCHEMBL26560280 0.83 DGKZ (0.45) SCDDGKZDGKA
SCHEMBL23526945 0.81 MEN1 (0.43) SCDDGKZMEN1KMT2ATP53
SCHEMBL31133788 0.81 MEN1 (0.43) SCDDGKZMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021133750-A1 SUBSTITUTED BICYCLIC PIPERIDINE DERIVATIVES USEFUL AS T CELL ACTIVATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-07-01 — — WO disclosed
Send feedback